SCHEMBL16919861

SCHEMBL16919861

Cc1ccc2c(c1)oc1cccnc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.42
▸ KDM4E B2RXH2 5/20 0.42
▸ NPC1 O15118 4/20 0.42
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ HSD17B10 Q99714 4/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ HPGD P15428 3/20 0.42
▸ TP53 P04637 2/20 0.42
▸ PKM P14618 1/20 0.42
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ MAOB P27338 1/20 0.39
▸ CCR1 P32246 3/20 0.39
▸ CCR8 P51685 3/20 0.39
▸ GAA P10253 1/20 0.38
▸ CCR5 P51681 2/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ PSMD14 O00487 2/20 0.38
▸ COPS5 Q92905 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21026835 0.87 COMT (0.42) NPC1SMN1; SMN2HSD17B10RAB9AHPGD
SCHEMBL13509561 0.86 NPC1 (0.41) ALDH1A1KDM4ENPC1SMN1; SMN2HSD17B10
SCHEMBL17705011 0.79 HTT (0.41) ALDH1A1KDM4ENPC1SMN1; SMN2TP53
SCHEMBL15631664 0.79 AHR (0.58) ALDH1A1KDM4ENPC1SMN1; SMN2HSD17B10
SCHEMBL17490113 0.79 ALDH1A1 (0.56) ALDH1A1KDM4ENPC1SMN1; SMN2HSD17B10
SCHEMBL22373875 0.79 L3MBTL1 (0.41) ALDH1A1KDM4ENPC1L3MBTL1HSP90AA1
SCHEMBL20172125 0.79 MEN1 (0.38) ALDH1A1KDM4ENPC1SMN1; SMN2HSD17B10
SCHEMBL25708738 0.79 TRPV1 (0.38) ALDH1A1KDM4ENPC1L3MBTL1HSP90AA1
SCHEMBL21237914 0.79 TBK1 (0.36) NPC1RAB9ATP53L3MBTL1HSP90AA1
SCHEMBL22336668 0.79 CCR1 (0.44) ALDH1A1KDM4ENPC1SMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230389413-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2023-11-30 — — US disclosed
US-20230389413-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2023-11-30 — — US disclosed
US-11758807-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION 2023-09-12 — — US disclosed
US-11758807-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION 2023-09-12 — — US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) 2023-06-01 — — US disclosed
US-20210367162-A1 HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-11-25 — — US disclosed
US-20200274081-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2020-08-27 — — US disclosed
US-10686142-B2 Condensed cyclic compound and organic light emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-06-16 — — US disclosed
US-9755159-B2 Organic materials for OLEDs UNIVERSAL DISPLAY CORPORATION (US) 2017-09-05 — — US disclosed
US-9502656-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2016-11-22 — — US disclosed
US-20160035986-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-02-04 — — US disclosed
US-20160035986-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-02-04 — — US disclosed
US-20150243907-A1 AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS BASF SE (DE) 2015-08-27 — — US disclosed
US-20150243893-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2015-08-27 — — US disclosed
US-20150207082-A1 ORGANIC MATERIALS FOR OLEDS UNIVERSAL DISPLAY CORPORATION (US) 2015-07-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230389413-A1 Organic Electroluminescent Materials and Devices GLRA3, ESRRG, GLRA1 ALDH1A1 2102/4885KDM4E 2665/4885NPC1 4127/4885
US-20200274081-A1 Organic Electroluminescent Materials and Devices GLRA3, ESRRG, GLRA1 ALDH1A1 2102/4885KDM4E 2665/4885NPC1 4127/4885
US-20150243907-A1 AZADIBENZOFURANS FOR ELECTRONIC APPLICATIONS AZI2, BRPF1, CCNB1 ALDH1A1 547/4885KDM4E 1361/4885NPC1 4635/4885
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 ALDH1A1 865/4885KDM4E 962/4885NPC1 2663/4885
US-20150207082-A1 ORGANIC MATERIALS FOR OLEDS OCIAD1, OCIAD2, SLC25A21 ALDH1A1 1012/4885KDM4E 1876/4885NPC1 419/4885
US-20230172057-A1 HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE CHRM1, CHRM2, CHRM4 ALDH1A1 3072/4885KDM4E 3767/4885NPC1 3859/4885
US-20160035986-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, CCNA1 ALDH1A1 362/4885KDM4E 2785/4885NPC1 2351/4885
US-10686142-B2 Condensed cyclic compound and organic light emitting device including the same CRY1, CCNT1, CRY2 ALDH1A1 142/4885KDM4E 3239/4885NPC1 1972/4885
US-11758807-B2 Organic electroluminescent materials and devices GLRA3, ESRRG, GLRA1 ALDH1A1 2102/4885KDM4E 2665/4885NPC1 4127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback